PREVENTIV MEASURES Trademark

Trademark Overview


On Thursday, October 29, 2009, a trademark application was filed for PREVENTIV MEASURES with the United States Patent and Trademark Office. The USPTO has given the PREVENTIV MEASURES trademark a serial number of 77860437. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Wednesday, September 29, 2010. This trademark is owned by Sagent Holding Co.. The PREVENTIV MEASURES trademark is filed in the Pharmaceutical Products category with the following description:

Labels sold as an integral component of pharmaceuticals, namely, alkalizing agents, analgesics and anesthetics, antacids, anticholinergics, anti-infectives, anti-inflammatory agents, anticonvulsants, antiemetics, anxiolytics, blood modifiers, cardiovasculars, diuretics, hormones, diluents, oncolytics, transplantation agents, imaging agents, vascular targeting agents, cancer treatments, and vascular disease treatments; Labels sold as an integral component of pre-filled syringes sold filled with alkalizing agents, labels sold as an integral component of pre-filled syringes sold filled with analgesics and anesthetics, labels sold as an integral component of pre-filled syringes sold filled with antacids, labels sold as an integral component of pre-filled syringes sold filled with anticholinergics, labels sold as an integral component of pre-filled syringes sold filled with anti-infectives, labels sold as an integral component of pre-filled syringes sold filled with anti-inflammatory agents...

General Information


Serial Number77860437
Word MarkPREVENTIV MEASURES
Filing DateThursday, October 29, 2009
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateWednesday, September 29, 2010
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesLabels sold as an integral component of pharmaceuticals, namely, alkalizing agents, analgesics and anesthetics, antacids, anticholinergics, anti-infectives, anti-inflammatory agents, anticonvulsants, antiemetics, anxiolytics, blood modifiers, cardiovasculars, diuretics, hormones, diluents, oncolytics, transplantation agents, imaging agents, vascular targeting agents, cancer treatments, and vascular disease treatments; Labels sold as an integral component of pre-filled syringes sold filled with alkalizing agents, labels sold as an integral component of pre-filled syringes sold filled with analgesics and anesthetics, labels sold as an integral component of pre-filled syringes sold filled with antacids, labels sold as an integral component of pre-filled syringes sold filled with anticholinergics, labels sold as an integral component of pre-filled syringes sold filled with anti-infectives, labels sold as an integral component of pre-filled syringes sold filled with anti-inflammatory agents, labels sold as an integral component of pre-filled syringes sold filled with anticonvulsants, labels sold as an integral component of pre-filled syringes sold filled with antiemetics, labels sold as an integral component of pre-filled syringes sold filled with anxiolytics, labels sold as an integral component of pre-filled syringes sold filled with blood modifiers, labels sold as an integral component of pre-filled syringes sold filled with cardiovasculars, labels sold as an integral component of pre-filled syringes sold filled with diuretics, labels sold as an integral component of pre-filled syringes sold filled with hormones, labels sold as an integral component of pre-filled syringes sold filled with diluents, labels sold as an integral component of pre-filled syringes sold filled with oncolytics, labels sold as an integral component of pre-filled syringes sold filled with transplantation agents, labels sold as an integral component of pre-filled syringes sold filled with imaging agents, labels sold as an integral component of pre-filled syringes sold filled with vascular targeting agents, labels sold as an integral component of pre-filled syringes sold filled with cancer treatments, and labels sold as an integral component of pre-filled syringes sold filled with vascular disease treatments; Labels sold as an integral component of injectable drugs and therapeutic solutions for the treatment of cancer and vascular diseases; labels sold as an integral component of injectable drugs and therapeutic solutions for the treatment of pain; labels sold as an integral component of injectable drugs and therapeutic solutions for the treatment of infections; labels sold as an integral component of injectable drugs and therapeutic solutions for the treatment of cardiovascular disease; labels sold as an integral component of injectable drugs and therapeutic solutions for the treatment of hormonal imbalances; labels sold as an integral component of injectable drugs and therapeutic solutions for the treatment of heartburn; labels sold as an integral component of injectable drugs and therapeutic solutions for imaging; Labels sold as an integral part of injectable drugs and therapeutic solutions for the treatment of cancer and vascular diseases sold in kits comprising pre-filled IV bags with devices for intravenous administration, namely, transfer pins, vials, needles, and adaptors; Labels sold as an integral part of injectable drugs and therapeutic solutions for the treatment of pain sold in kits comprising pre-filled IV bags with devices for intravenous administration, namely, transfer pins, vials, needles, and adaptors; Labels sold as an integral part of injectable drugs and therapeutic solutions for the treatment of infections sold in kits comprising pre-filled IV bags with devices for intravenous administration, namely, transfer pins, vials, needles, and adaptors; Labels sold as an integral part of injectable drugs and therapeutic solutions for the treatment of cardiovascular disease sold in kits comprising pre-filled IV bags with devices for intravenous administration, namely, transfer pins, vials, needles, and adaptors; Labels sold as an integral part of injectable drugs and therapeutic solutions for the treatment of hormonal imbalances sold in kits comprising pre-filled IV bags with devices for intravenous administration, namely, transfer pins, vials, needles, and adaptors; Labels sold as an integral part of injectable drugs and therapeutic solutions for the treatment of heartburn sold in kits comprising pre-filled IV bags with devices for intravenous administration, namely, transfer pins, vials, needles, and adaptors; Labels sold as an integral part of injectable drugs and therapeutic solutions for imaging sold in kits comprising pre-filled IV bags with devices for intravenous administration, namely, transfer pins, vials, needles, and adaptors
Pseudo MarkPREVENTIVE MEASURES

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, November 4, 2009
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameSagent Holding Co.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressGeorgetown
KY

Trademark Events


Event DateEvent Description
Wednesday, September 29, 2010ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Wednesday, September 29, 2010ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Thursday, February 4, 2010NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, February 4, 2010NON-FINAL ACTION E-MAILED
Thursday, February 4, 2010NON-FINAL ACTION WRITTEN
Wednesday, February 3, 2010ASSIGNED TO EXAMINER
Thursday, November 5, 2009NOTICE OF PSEUDO MARK MAILED
Wednesday, November 4, 2009NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, November 2, 2009NEW APPLICATION ENTERED IN TRAM